How to Buy Adapthealth Stock
Adapthealth Corp
AdaptHealth Corp. , together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States.
Adapthealth stock last closed at $7.33, down 5.91% from the previous day, and has decreased 23.65% in one year. It has underperformed other stocks in the Medical Devices industry by 0.05 percentage points. Adapthealth stock is currently +3.17% from its 52-week low of $7.11, and -38.4% from its 52-week high of $11.90.
There are currently 134.87M shares of AHCO outstanding. The market value of AHCO is $988.58M. In the past 24 hours, 1.64M AHCO shares were traded.
How to Buy Adapthealth Stock
Not sure how to invest in Adapthealth stock? Here's how.
- Decide where to buy Adapthealth stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Adapthealth stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Pick your payment method and add your information.
- Evaluate Adapthealth stock: The Adapthealth ticker symbol is AHCO. Is Adapthealth stock a good investment? Should you buy shares of AHCO? How do AHCO's underlying business fundamentals look? Do top analysts think Adapthealth is a good buy? Why has AHCO's stock price moved recently? (Hint: Our stock market research website can help you evaluate if AHCO is a good stock to buy).
- Make your AHCO buy order: Decide if you will purchase AHCO shares at the current market price or use a limit order to purchase AHCO shares at a particular price.
- Track your AHCO position: Create a watchlist to important notifications about your position in Adapthealth shares.
Step 1: Decide where to buy Adapthealth stock
You need an online brokerage account to access the NASDAQ market and buy AHCO stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal information so you are able to invest in AHCO stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start your new brokerage account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've opened your account on the best stock trading app, you need to deposit funds:
Check out the tutorial below if you need help depositing money into your new investment account.
Step 4: Evaluate Adapthealth stock
Once you have decided on the best place to buy Adapthealth stock, it's crucial to analyze their stock before you buy, so you can understand the risk as well as the opportunity.
Adapthealth shares quick numbers
AHCO Due Diligence Score
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on AHCO's stock page.
Is AHCO stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge AHCO's intrinsic value.
Using relative valuations metrics:
- AHCO could be undervalued based on its P/E ratio of 11.82x, relative to Medical Devices industry P/E ratio of 40.34x
- AHCO may be undervalued based on its P/B ratio of 0.63x, relative to Medical Devices industry P/B ratio of 3.74x
- AHCO could be undervalued based on its PEG ratio of 0.28x
You can access more valuation research on AHCO's stock here.
Is AHCO a healthy company?
Passed Financial Due Diligence Checks:
- AHCO profit margin has gone up from -21.2% to 2.8% in the past year.
- AHCO's operating cash flow of $541.84M allows it to safely service it's debt of $2.13B.
- Total AHCO debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the AHCO balance sheet.
Failed Financial Due Diligence Checks:
- AHCO earnings of $258.33M is not enough to cover its interest payments.
- There are more long-term liabilities than short-term assets on the AHCO balance sheet.
- AHCO has a relatively high debt to equity ratio of 1.85.
Is AHCO stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 5 Equities analysts who give recommendations on AHCO, the consensus analyst rating on Adapthealth is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Adapthealth stock forecast page.
AHCO Technical Indicators
AHCO Growth Numbers
Last year, AHCO earnings were $90.42M. Over the past 3 year, AHCO's earnings have gone up by -76.43% per year. This was slower than the Medical Devices industry average of 10.23%.
Last year, AHCO revenue was $3.26B. Over the last 5 year, AHCO's revenue has gone up by 43.84% per year. This was faster than the Medical Devices industry average of 9.8%.
Find out more about AHCO's earnings and revenue performance here.
Are AHCO executives and large shareholders buying or selling the stock?
In the last year, insiders at AHCO have sold more shares than they have bought.
Jason A. Clemens, Chief Financial Officer of AHCO, was the latest AHCO insider to sell. They sold $327,250.00 worth of AHCO stock on Dec 10, 2024.
Learn more about who owns AHCO shares here.
Can I get consistent income from AHCO stock?
No, Adapthealth doesn't provide an income stream by paying out dividends.
What do other investors have to say about AHCO?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your AHCO buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, place a limit order.
Hit the Open button and eToro will execute your order.
If you require additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Track your AHCO position
Now that you own some AHCO shares, you'll want to stay up-to-date on your shares.
Make a watchlist to track the latest developments regarding your AHCO stock.
AHCO Feed
How to Buy Stock in Adapthealth
To reiterate, here are the 6 steps you need to take to buy Adapthealth stock right now:
- Decide where to buy Adapthealth stock
- Sign up for your brokerage account
- Put funds into your brokerage account
- Evaluate Adapthealth stock
- Make your AHCO buy order
- Track your AHCO position
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Adapthealth, hit the button below to create your watchlist.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.